Is Celsion CORP Stock a good buy in 2020, according to Wall Street analysts?What is CLSN's earnings growth forecast for 2020-2022?What is CLSN's revenue growth forecast for 2020-2022?What is CLSN's Earnings Per Share (EPS) forecast for 2020-2022?What is CLSN's forecast return on equity (ROE) for 2020-2023?What is CLSN's forecast return on assets (ROA) for 2020-2023?CLSN's Return on Equity is forecast to be low in 4 years (-28.20%); analysts are not confident in the firm's ability to efficiently generate return on equityCLSN is forecast to generate lower Return on Assets (-14.61%) than the US Biotechnology industry average (-0.61%)CLSN's revenue is forecast to grow at a rate of 1.48% per year, which is not exceptionalCLSN's revenues are forecast to grow slower (1.48% per year) than the US Biotechnology industry average (41.43%)CLSN's revenues are forecast to grow slower (1.48% per year) than the US market average (4.82%)The consensus among 3 Wall Street analysts covering (NASDAQ: CLSN) stock is to Buy CLSN stock.Out of 3 analysts, 1 (33.33%) are recommending CLSN as a Strong Buy, 0 (0.00%) are recommending CLSN as a Buy, 2 (66.67%) are recommending CLSN as a Hold, 0 (0.00%) are recommending CLSN as a Sell, and 0 (0.00%) are recommending CLSN as a Strong Sell.According to 1 Wall Street analysts that have issued a 1 year CLSN price target, the average CLSN price target is $4.00, with the highest CLSN stock price forecast at $4.00 and the lowest CLSN stock price forecast at $4.00.On average, Wall Street analysts predict that Celsion CORP's share price could reach $4.00 by Jul 15, 2021. bad, high-risk 1-year investment option. On average, 3 Wall Street analysts forecast CLSN's earnings for 2021 to be $-11,313,721, with the lowest CLSN earnings forecast at $-15,213,693, and the highest CLSN earnings forecast at $-7,314,275. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors.
Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC.
CLSN stock price predictions 2020,
Celsion Corp. market prognosis,
Question Box:
Sporting 5.55% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Tuesday, Sep 01 when the CLSN stock price touched $0.949 or saw a rise of 13.59%. future.
Q&A about "CLSN" projections. The stock analysis for Celsion Corporation (CLSN) is based on the analysis and stock picks of our best trading systems. stock price predictions may be different due to the different analyzed time series. Celsion Corporation [NASDAQ: CLSN] stock went on a downward path that fall over -2.83% on Monday, amounting to a one-week price decrease of less than -7.21%. days (3 - 30)
Find market predictions, CLSN financials and market news. Post-Market 0.04 (5.39%) Ratan Tata Invests in 18-year old’s Venture Generic Aadhaar
Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Help us improve our free forecast service with share!
2 Wall Street analysts have issued ratings and price targets for Celsion in the last 12 months. Celsion Corporation is a fully integrated oncology company with a high-potential portfolio of innovative cancer treatments.
Be the first to comment.
Term Box:
(NASDAQ: CLSN) Celsion CORP's forecast annual revenue growth rate of 1.48% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 41.43%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 4.82%.Celsion CORP's revenue in 2020 is $500,000.On average, 3 Wall Street analysts forecast CLSN's revenue for 2020 to be $11,117,698, with the lowest CLSN revenue forecast at $3,803,423, and the highest CLSN revenue forecast at $14,921,122. Their average twelve-month price target is $4.00, predicting that the stock has a possible upside of 414.87%.
The company report on August 14, 2020 that Celsion Corporation Reports Second Quarter 2020 Financial Results and Provides Business Update. All times are ET.
Current Price
CLSN stock future price,
Short-term and long-term CLSN (Celsion Corp.)
Investors in Celsion Corporation CLSN need to pay close attention to the stock based on moves in the options market lately. View CLSN revenue estimates and earnings estimates, as well as analyst recommendations. In 2022, CLSN is forecast to generate $14,628,551 in revenue, with the lowest revenue forecast at $14,628,551 and the highest revenue forecast at $14,628,551.WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Stock Predictons by days: 2020 Search Stock, FX pair, Crypto, or Commodity... Celsion Corporation Stock Forecast and Price Prognosis Data for 2020 The average Celsion CORP stock price prediction forecasts a potential downside of 73.50% from the current CLSN share price of $1.06. With platform technologies in chemotherapy and gene-mediated immunotherapy, and RNAi engineered to enhance the clinical benefits of proven agents, Celsion’s mission is transformational. Since then, CLSN shares have decreased by 17.2% and is now trading at $0.82. Not within a year. CLSN stock price prediction,
View live CELSION CORPORATION chart to track its stock's price action.
Predictions, Comments & Questions
Set an interval! https://aadhaar-articles.blogspot.com/
Is CLSN stock price going to drop? 2020 Copyrighted By:
Celsion is a fully integrated oncology company focused on developing a portfolio of innovative cancer treatments, including directed chemotherapies, immunotherapies and RNA- … The average Celsion CORP stock price prediction forecasts a potential downside of 79.45% from the current CLSN share price of $0.82.